Leukemia Clinical Trials

Showing 3261-3280 of 5,235 trials

Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

NCT04355806

This project is to assess the immunogenicity, safety and overall survival impact of intramuscular injection of trivalent influenza vaccine in non-small cell lung cancer (NSCLC) patients with PD-1/PD-L1 inhibitor treatment.

Non Small Cell Lung CancerInfluenza Vaccine

Shanghai Pulmonary Hospital, Shanghai, China160 participantsStarted Jun 2020

Hong Kong, Hong Kong, China • Shanghai, Shanghai Municipality, China

UNKNOWN

Immune Response Features in Allergic Airway Diseases

NCT04352088

This study aims to investigate immune mechanisms and phenotypes and endotypes of allergic airway diseases - allergic rhinitis and allergic asthma. Pathogenesis of these diseases are not fully investigated yet. Patients with the same disease have different dominant symptoms, course of the disease and response to treatment. Moreover, there is a hypothesis about united airway disease suggesting that allergic rhinitis and allergic asthma is different manifestation of the same disease. This led to assumption of phenotypes and endotypes. This classification which still is not unified can let to prescribe personalized treatment for every patient.

Allergic RhinitisAllergic Asthma

Lithuanian University of Health Sciences150 participantsStarted May 2019

Kaunas, Lithuania

COMPLETEDNA

Multifactorial Falls Prevention Program - Brazil

NCT01698580

This study is a clinical trial designed to evaluate the effectiveness of a multifactorial falls prevention program in reducing the rate of falls. A multifactorial falls prevention program consisting of an individualized medical management of the modifiable risk factors, a progressive on-site body balance exercise plus a home-based exercise program, an educational/behavioral intervention and a fall prevention booklet will reduce the number of falls and fall rates when compared with usual care.

Accidental Falls

University of Sao Paulo612 participantsStarted Dec 2013

São Paulo, Brazil

Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

Immune Response Features in Allergic Airway Diseases

Multifactorial Falls Prevention Program - Brazil

Related Searches

Tosedostat and Cytarabine or Azacitidine in Treating Older Participants With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia

Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia

Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia

Treatment of High Risk Adult Acute Lymphoblastic Leukemia

UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.

Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC

Transcranial Magnetic Stimulation for "Voices"

Analyses of Human Samples Collected in Clinical Trials

Improving Balance and Mobility

MM-398 and Ramucirumab in Treating Patients With Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

NGS Combined With RNAseq on Tumor Immune Escape in NSCLC

Anlotinib In Combination With Durvalumab As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm Study

10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1

The Role of Ruxolitinib in Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Neoplasm